1Becker RC,Burns M,Gore JM,et al.Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice.The National Registry of Myocardial Infarction (NRMI-2) Participants.Am Heart J,1998,135(5 Pt 1): 786-796.
2Grines C,Patel A,Zijlstra F,et al.Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.Am Heart J,2003,145(1): 47-57.
4Schmedtje JF Jr,Evans GW,Byerly W,et al.Treatment of chronic heart failure in a managed care setting.Baseline results from the Achieving Cardiac Excellence Project.N C Med J,2003,Jan-Feb,64(1): 4-10.
5Helman DN.Oz MC.Developing a comprehensive mechanical support program.Card Surg,2001,16(3): 203-208.
4Stankovic I, Neskovie AN, Putnikovic B, et al. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure-insight from the Cardiac Insufficiency Bisoprolol Study in Elderly [ J ]. Int J Cardiol,2012,161 ( 3 ) : 160 - 165.
5Zhang S, He B, Goldstein S, et al. Changes in adiponectin expression in acute myocardial infarction rats and the significance of bisoprolol intervention [ J ]. Can J Physiol Pharmacol, 2011,89 ( 2 ) : 109 - 115.
6de Man FS, Handoko 'ML, van Ballegoij J J, et al. Bisoprolol delays progression towards right heart failure in experimental pulmonary hy- pertension [ J ]. Circ Heart Fail,2012,5 ( 1 ) :97 - 105.
7Chopra HK. Bisoprolol and heart failure: new frontiers[ J]. Indian Heart J,2010,62 ( 1 ) :7 - 12.
